01 April, 2013
印度最高法院驳回瑞士诺华制药公司(Novartis)对治癌药Glivec的专利申请。
星期一，印度最高法院做出具有里程碑意义的裁决，拒绝给予升级版Glivec专利保护。
这项裁决将成为一项先例，防止国际制药公司就既有药品的升级版从印度获得新专利保护。
根据印度法律，公司不得为仅做细微变动的既有药品申请专利。
印度最高法院星期一裁定，升级版Glivec不具备印度专利法所要求的创新性质。
这项裁决是印度拥有巨额利润的非专利药制造业界的胜利，这一产业为世界各地数以百万计的人提供廉价药。
India's Supreme Court has rejected a patent bid by Swiss drug maker Novartis for a cancer drug.
In a landmark ruling Monday, the court dismissed patent protection to an updated version of the drug Glivec.
The ruling is a precedent that prevents international pharmaceutical companies from obtaining fresh patents in India on updated versions of existing drugs.
India's law prevents companies from seeking patents for making only slight modifications to an existing drug.
The Supreme Court decided Monday the updated Glivec did not satisfy the "novelty" aspect required by Indian patent law.
The ruling is a victory for India's multi-billion-dollar generic drug industry that provides cheap medicines to millions around the world.
Novartis has been fighting since 2006 to win a patent for the amended form of Glivec.
瑞士诺华制药公司在印度打输专利官司 Drug Maker Loses India Patent Battle
Related Articles
- 韩国总统命令军队应对朝鲜挑衅可不计政治后果 South Korean President Orders Military to Act Without Political Considerations Against North Korean Actions (13/4/1)
- 朝鲜火箭部队奉命做好袭击美国的准备 North Korea Readies Rocket Units for Attacks on U.S. (13/3/29)
- 南非总统：曼德拉目前状况“非常好” S.Africa President:Mandela Doing 'Very Well' (13/3/29)
- 朝鲜半岛南北过境点在平壤切断热线后仍运作 Border Crossing Still Operating after NKorea Cuts Hotline with South (13/3/28)
- 塞浦路斯各家银行在严密控制下恢复营业 Cyprus Reopens Banks Under Tight Controls (13/3/28)
- 缅甸：担心穆斯林和佛教徒之间暴力冲突 Burma: Fears of Long-Term Segregation Following Buddhist-Muslim Violence (13/3/27)
- 联合国秘书长潘基文：需在马里部署两支维和部队 UN's Ban to Ask for 2 Separate Forces for Mali (13/3/27)
- 在阿富汗东部自杀爆炸手炸死5名警察 Suicide Bombers Kill 5 Police in Eastern Afghanistan (13/3/26)
- 朝鲜威胁攻击关岛、夏威夷及美国本土 NKorea Threatens Attacks on Guam, Hawaii, US Mainland (13/3/26)
- 联合国秘书长谴责中非共和国反政府武装夺取政权 UN Chief Condemns Rebel Seizure in CAR (13/3/25)
